Impact of <scp>HBV</scp> serological status on <scp>HIV</scp> virological efficacy of two‐drug antiretroviral regimens: A retrospective observational study on virologically suppressed people with <scp>HIV</scp> switching to lamivudine/dolutegravir
The study supports the virological efficacy of 3TC/DTG-based 2DR in PWH, regardless of HBV serological status. Isolated anti-HBc positivity did not influence virological outcomes independently. Larger studies are warranted to further investigate HIV-HBV interactions in this context.
Authors
- Arturo Ciccullo (ORCID: https://orcid.org/0000-0001-5941-883X)
- Elena Visconti
- Francesca Lombardi (ORCID: https://orcid.org/0000-0001-5757-8346)
- Pierluigi Francesco Salvo (ORCID: https://orcid.org/0000-0001-7559-7364)
- Gianmaria Baldin (ORCID: https://orcid.org/0000-0003-4623-9976)
- Carlo Torti
- Simona Di Giambenedetto
Institutions
- Università Cattolica del Sacro Cuore (IT)
- Agostino Gemelli University Polyclinic (IT)
- San Salvatore Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- HIV Medicine
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1111/hiv.13765
- Citations
- 1
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35